BIOMAT Database Logo BIOMAT Database Logo

Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates. 1998

J J McSharry, and N S Lurain, and G L Drusano, and A L Landay, and M Notka, and M R O'Gorman, and A Weinberg, and H M Shapiro, and P S Reichelderfer, and C S Crumpacker
Albany Medical College, Albany, New York 12208, USA. jim_mcsharry@ccgateway.amc.edu

Rapid, quantitative, and objective determination of the susceptibilities of human cytomegalovirus (HCMV) clinical isolates to ganciclovir has been assessed by an assay that uses a fluorochrome-labeled monoclonal antibody to an HCMV immediate-early antigen and flow cytometry. Analysis of the ganciclovir susceptibilities of 25 phenotypically characterized clinical isolates by flow cytometry demonstrated that the 50% inhibitory concentrations (IC50s) of ganciclovir for 19 of the isolates were between 1.14 and 6.66 microM, with a mean of 4.32 microM (+/-1.93) (sensitive; IC50 less than 7 microM), the IC50s for 2 isolates were 8.48 and 9.79 microM (partially resistant), and the IC50s for 4 isolates were greater than 96 microM (resistant). Comparative analysis of the drug susceptibilities of these clinical isolates by the plaque reduction assay gave IC50s of less than 6 microM, with a mean of 2.88 microM (+/-1.40) for the 19 drug-sensitive isolates, IC50s of 6 to 8 microM for the partially resistant isolates, and IC50s of greater than 12 microM for the four resistant clinical isolates. Comparison of the IC50s for the drug-susceptible and partially resistant clinical isolates obtained by the flow cytometry assay with the IC50s obtained by the plaque reduction assay showed an acceptable correlation (r2 = 0.473; P = 0.001), suggesting that the flow cytometry assay could substitute for the more labor-intensive, subjective, and time-consuming plaque reduction assay.

UI MeSH Term Description Entries
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015774 Ganciclovir An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. BIOLF-62,BW-759,Cytovene,Ganciclovir Sodium,Ganciclovir, Monosodium Salt,Gancyclovir,RS-21592
D017874 Immediate-Early Proteins Proteins that are coded by immediate-early genes, in the absence of de novo protein synthesis. The term was originally used exclusively for viral regulatory proteins that were synthesized just after viral integration into the host cell. It is also used to describe cellular proteins which are synthesized immediately after the resting cell is stimulated by extracellular signals. Proteins, Immediate-Early,Immediate Early Proteins,Proteins, Immediate Early

Related Publications

J J McSharry, and N S Lurain, and G L Drusano, and A L Landay, and M Notka, and M R O'Gorman, and A Weinberg, and H M Shapiro, and P S Reichelderfer, and C S Crumpacker
Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir.
October 2005, Journal of clinical microbiology,
J J McSharry, and N S Lurain, and G L Drusano, and A L Landay, and M Notka, and M R O'Gorman, and A Weinberg, and H M Shapiro, and P S Reichelderfer, and C S Crumpacker
Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures.
November 1992, Journal of clinical microbiology,
J J McSharry, and N S Lurain, and G L Drusano, and A L Landay, and M Notka, and M R O'Gorman, and A Weinberg, and H M Shapiro, and P S Reichelderfer, and C S Crumpacker
Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry.
June 1996, Journal of clinical microbiology,
J J McSharry, and N S Lurain, and G L Drusano, and A L Landay, and M Notka, and M R O'Gorman, and A Weinberg, and H M Shapiro, and P S Reichelderfer, and C S Crumpacker
Ganciclovir-resistant human cytomegalovirus clinical isolates; resistance mechanisms and in vitro susceptibility to antiviral agents.
June 1991, Transplantation proceedings,
J J McSharry, and N S Lurain, and G L Drusano, and A L Landay, and M Notka, and M R O'Gorman, and A Weinberg, and H M Shapiro, and P S Reichelderfer, and C S Crumpacker
Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir.
November 1991, Antimicrobial agents and chemotherapy,
J J McSharry, and N S Lurain, and G L Drusano, and A L Landay, and M Notka, and M R O'Gorman, and A Weinberg, and H M Shapiro, and P S Reichelderfer, and C S Crumpacker
Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
August 2005, Journal of microbiological methods,
J J McSharry, and N S Lurain, and G L Drusano, and A L Landay, and M Notka, and M R O'Gorman, and A Weinberg, and H M Shapiro, and P S Reichelderfer, and C S Crumpacker
Evaluation of rapid colistin susceptibility directly from positive blood cultures using a flow cytometry assay.
December 2019, International journal of antimicrobial agents,
J J McSharry, and N S Lurain, and G L Drusano, and A L Landay, and M Notka, and M R O'Gorman, and A Weinberg, and H M Shapiro, and P S Reichelderfer, and C S Crumpacker
Rapid antimicrobial susceptibility testing of urinary tract isolates and samples by flow cytometry.
March 2002, Journal of medical microbiology,
J J McSharry, and N S Lurain, and G L Drusano, and A L Landay, and M Notka, and M R O'Gorman, and A Weinberg, and H M Shapiro, and P S Reichelderfer, and C S Crumpacker
Susceptibility of clinical isolates of cytomegalovirus to human interferon.
April 1977, Antimicrobial agents and chemotherapy,
J J McSharry, and N S Lurain, and G L Drusano, and A L Landay, and M Notka, and M R O'Gorman, and A Weinberg, and H M Shapiro, and P S Reichelderfer, and C S Crumpacker
Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir.
October 2001, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!